07th August, 2020
Observe Medical has entered into an updated distribution agreement and strengthened partnership with SIM Italia S.r.l. for the launch of Sippi® in the Italian market.
“We are pleased to announce our strengthened partnership with SIM Italia and the signing of an updated distribution agreement for the important Italian market. SIM Italia is a well-established and professional partner, highly committed to launch Sippi® in Italy together with us, to the benefit of the Italian healthcare system and patients,” says Björn Larsson, CEO of Observe Medical.
Sippi® is the only automated digital urine meter with wireless data transfer to the hospital patient data management systems, also hindering bacterial migration that can lead to urinary infections. Sippi® is CE marked and is currently being launched at selected hospitals in Europe.
“The COVID-19 outbreak in Italy and globally has put healthcare systems under a tremendous pressure. The pandemic has emphasized the need for accurate patient data, the need to prevent and manage hospital acquired infections and the acute need for increased capacity and efficiency in intensive care units. Although the pandemic has slowed some of our initial launch activities, it has underpinned the need for a system like Sippi® and we expect it to be a strong driver for both volume and value growth in the future,” says Larsson and concludes:
“We are preparing our organization to capture this growth opportunity, including keeping close contact with our customers and partners globally, as displayed by this strengthened partnership. We are looking forward to work together with SIM Italia for a successful launch and roll-out of Sippi® in Italy“.